- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Sclerosis, Relapsing, Remitting in United States
Total 1446 results
-
Washington Neuropsychology Research GroupGenzyme, a Sanofi CompanyUnknownRelapsing Remitting Multiple SclerosisUnited States
-
National Institute of Allergy and Infectious Diseases...PPD; Rho Federal Systems Division, Inc.; Immune Tolerance Network (ITN); Blood...RecruitingRelapsing Multiple Sclerosis | Relapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Amanda IrishCompletedMultiple Sclerosis, Relapsing-remittingUnited States
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple SclerosisPoland, Hungary, Turkey, Spain, Germany, United States, Canada, Switzerland, Russian Federation, Norway, Italy, Finland
-
BayerCompletedMultiple SclerosisUnited States, Canada
-
Beijing InnoCare Pharma Tech Co., Ltd.Active, not recruitingRelapsing Remitting Multiple SclerosisChina, United States, Ukraine, Poland
-
NHS Greater Glasgow and ClydeBiogenEnrolling by invitationRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Anokion SAActive, not recruitingRelapsing Remitting Multiple Sclerosis | Multiple Sclerosis (MS)United States
-
Apitope Technology (Bristol) Ltd.Aptiv Solutions; ClinStar, LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom, Russian Federation
-
Terry L. WahlsActive, not recruitingClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisHungary, Turkey, Spain, Germany, Canada, Switzerland, United States, Norway, Russian Federation, Italy, Finland, Poland
-
Queen Mary University of LondonMerck Sharp & Dohme LLCCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
Johns Hopkins UniversityUniversity of Pennsylvania; Washington University School of Medicine; Yale University and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
University of VirginiaNational Multiple Sclerosis SocietyUnknownClinically Isolated Syndrome | Relapsing Remitting Multiple SclerosisUnited States
-
BiogenCompletedMultiple SclerosisUnited States, Italy, Hungary, United Kingdom, Spain, France, Australia, Germany, Canada, Switzerland, Argentina, Czech Republic, Croatia
-
Genzyme, a Sanofi CompanyCompletedRelapsing Remitting Multiple SclerosisUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czechia, Denmark, Germany, Israel, Italy, Mexico, Netherlands, Poland, Russian Federation, Spain, Sweden, Ukraine, United Kingdom
-
Teva Pharmaceutical Industries, Ltd.TerminatedRelapsing Remitting Multiple SclerosisCzechia, Germany, Hungary, Israel, Italy, Poland, Russian Federation, Spain, United Kingdom
-
University of Alabama at BirminghamWashington University School of Medicine; United States Department of DefenseRecruitingRelapsing Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of California, Los AngelesJohns Hopkins University; University of Colorado, Denver; Mayo Clinic; University... and other collaboratorsCompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
GlaxoSmithKlineCompletedMultiple SclerosisItaly, Germany, Spain, United Kingdom, Australia, Netherlands, New Zealand, Russian Federation, France, Canada, Austria, Poland, Finland, Norway
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited Kingdom
-
BiogenElan PharmaceuticalsTerminatedRelapsing Remitting Multiple SclerosisUnited States, Czech Republic, Italy, Spain, Sweden, Latvia, Finland, Hungary, Poland, Slovenia, Australia, Canada, France
-
NovartisCompletedMultiple SclerosisGreece, Russian Federation, Switzerland, Germany, Israel, Ireland, Belgium, Finland, United Kingdom, Netherlands, Canada, Romania, Hungary, Poland, Czech Republic, Australia, Estonia, France, Slovakia, South Africa, Sweden, Turkey
-
NovartisCompletedMultiple SclerosisUnited States, Turkey, Romania, United Kingdom, Poland, Austria, Canada, Australia
-
Contineum TherapeuticsRecruitingRelapsing Remitting Multiple SclerosisUnited States
-
GlaxoSmithKlineCompletedMultiple SclerosisUnited States, Bulgaria, Russian Federation, Spain, Germany, Czechia, Netherlands, Norway, Italy, Canada, Denmark
-
Genentech, Inc.CompletedMultiple SclerosisUnited States
-
EMD SeronoMerck KGaA, Darmstadt, Germany; Ono Pharmaceutical Co. LtdTerminatedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Japan, Poland, Russian Federation, Spain, Ukraine, Greece
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Spain
-
University of Colorado, DenverCompleted
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Argentina, Austria, Belgium, Croatia, Finland, France, Germany, Ireland, Italy, Mexico, Poland, Puerto Rico, Russian Federation, Spain, Turkey
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
ActelionCompletedMultiple SclerosisPoland, Ukraine, United Kingdom, United States, Germany, Spain, Bulgaria, Romania, Serbia, Canada, Finland, Sweden, Russian Federation, Hungary, Czechia, Netherlands, Israel, Switzerland, Austria, France
-
Synthon BVCompletedMultiple SclerosisUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Germany, Italy, Mexico, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
-
Fred LublinNational Institute of Neurological Disorders and Stroke (NINDS)CompletedRelapsing Remitting Multiple SclerosisUnited States, Canada
-
ActelionCompletedMultiple SclerosisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Finland, France, Germany, Hungary, Israel, Italy, Netherlands, Poland, Romania, Russian Federation, Serbia, Spain, Sweden, Switzerland, Ukraine, United Kingdom
-
EMD SeronoTerminatedRelapsing Remitting Multiple SclerosisUnited States, Croatia, Bulgaria, Czech Republic, Italy, Mexico, Russian Federation, South Africa, Spain, Turkey, Hungary, Poland, Ukraine, Finland, United Kingdom, Greece, Serbia
-
Ono Pharma USA IncCompletedMultiple SclerosisUnited States, Belgium, Canada, Czech Republic, Germany, Greece, Japan, Poland, Russian Federation, Spain, Ukraine
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Hungary, Israel, Italy, Lithuania, Poland, Romania, Russian Federation, South Africa, Ukraine, United Kingdom
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
Novartis PharmaceuticalsCompletedRelapsing Remitting Multiple SclerosisUnited States, Puerto Rico
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Estonia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Moldova, Republic of, Montenegro, North Macedonia and more
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Croatia, Czechia, Estonia, Georgia, Germany, Israel, Italy, Lithuania, North Macedonia, Poland, Puerto Rico, Romania, Russian Federation, Slovakia, South Africa, Spain, Ukraine
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
BiogenCompletedDoes Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? (FLAIR)Relapsing Remitting Multiple SclerosisBelgium, Luxembourg, United Kingdom
-
University of VermontCompletedFatigue | Sleep Initiation and Maintenance Disorders | Relapsing Remitting Multiple SclerosisUnited States
-
Acorda TherapeuticsPRA Health SciencesCompletedMultiple Sclerosis, Acute RelapsingUnited States
-
University of Southern CaliforniaTeva Pharmaceuticals USACompletedRelapsing Remitting Multiple SclerosisUnited States
-
Johns Hopkins UniversityUnited States Department of DefenseCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveUnited States